February 16, 2021
Today, healthcare in the United States encompasses a disproportionate amount of the economy, hovering just below 20% of Gross Domestic Product (GDP). It has been immune to rational market forces that would ultimately drive competition and value in any other industry. No other country in the world has faced such high cost and low return as measured by life expectancy, chronic disease burden, outcomes, equity, and ultimately public trust. Click here to read more>>